Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131429) titled 'Effects of calcium ß-hydroxy-ß-methylbutyrate (CaHMB) fortified oral nutritional supplementation on muscle condition and clinical outcomes after gastrointestinal tumor surgery' on Sept. 2.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shanghai Sixth people's Hospital
Condition:
Gastrointestinal tumor
Intervention:
Experimental group:Oral supplementation with a nutritional supplement containing 3g CaHMB daily for 30 consecutive days starting from postoperative days 3 to 5.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-02
Target S...